An investigation into the effect of the type IV phosphodiesterase inhibitor rolipram in the modulation of glutamate release from rat prefrontocortical nerve terminals

Synapse

Volumn 59, Issue 1, 2006, Pages 41-50

  Wang, Su Jane ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

cAMP dependent protein kinase; Cognition; Glutamate exocytosis; Phosphodiesterase inhibitor; Prefrontocortical synaptosomes

Indexed keywords

4 AMINOPYRIDINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CALCIUM IONOPHORE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; IONOMYCIN; KT 5720; OMEGA CONOTOXIN MVIIC; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EXOCYTOSIS; LEARNING; MALE; MEMORY; NERVE CELL MEMBRANE POTENTIAL; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SYNAPSE VESICLE;

4-AMINOPYRIDINE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLUTAMIC ACID; MALE; MEMBRANE POTENTIALS; OMEGA-CONOTOXINS; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHLORIDE; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM; SYNAPTOSOMES; THIONUCLEOTIDES; TIME FACTORS;

EID: 28244461592     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20212     Document Type: Article

References (37)

1. Aigner TG. 1995. Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5:155-160.
2. 2(5). J Neurochem 48:552-559.
3. Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R, Mansuy I, Hawkins RD, Kandel ER. 1999. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci USA 96:5280-5285.
4. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E. 1998. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci U S A 95:15020-15025.
5. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
6. Cherry JA, Davis RL. 1999. Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407:287-301.
7. Chheda MG, Ashery U, Thakur P, Rettig J, Sheng ZH. 2001. Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex. Nat Cell Biol 3:331-338.
8. Francis PT, Sims NR, Procter AW, Bowen DM. 1993. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J Neurochem 60:1589-1604.
9. Gereau RW, Conn PJ. 1994. Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron 12:1121-1129.
10. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. 2004. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114:1624-1634.
11. Greengard P. 2001. The neurobiology of slow synaptic transmission. Science 294:1024-1030.
12. Greengard P, Valtorta F, Czernik AJ, Benfenati F. 1993. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259:780-785.
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
14. Laurenza A, Sutkowski EM, Seamon KB. 1989. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci 10:442-447.
15. Li M, West JW, Numann R, Murphy BJ, Scheuer T, Catterall WA. 1993. Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science 261:1439-1442.
16. Lipton SA, Rosenberg PA. 1994. Excitatory amino acids as & final common pathway for neurological disorders. New Eng J Med 330:613-622.
17. Lonart G, Janz R, Johnson KM, Sudhof TC. 1998. Mechanism of action of rab3A in mossy fiber LTP Neuron 21:1141-1150.
18. Malgaroli A, Tsien RW. 1992. Glutamate-induced long-term potentiation of the frequency of miniature synaptic currents in cultured hippocampal neurons. Nature 357:134-139.
19. Nicholls DG. 1993. The glutamatergic nerve terminal. Eur J Biochem 212:613-631.
20. Nicholls DG, Sihra TS. 1986. Synaptosomes possess an exocytotic pool of glutamate. Nature 321:772-773.
21. Nicholls DG, Sihra TS, Sanchez-Prieto J. 1987. Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 49:50-57.
22. Nielander HB, Onofri F, Valtorta F, Schiavo G, Montecucco C, Greengard P, Benfenati F. 1995. Phosphorylation of VAMP/synaptobrevin in synaptic vesicles by endogenous protein kinases. J Neurochem 65:1712-1720.
23. + channels of the mammalian brain. FASEB J 5:164-170.
24. Rink TJ, Montecucco C, Hesketh TR, Tsien RY. 1980. Lymphocyte membrane potential assessed with fluorescent probes. Biochim Biophys Acta 595:15-30.
25. Risinger C, Bennett MK. 1999. Differential phosphorylation of syntaxin and synaptosome-associated protein of 25 kDa (SNAP-25) isoforms. J Neurochem 72:614-624.
26. Sihra TS. 1997. Protein phosphorylation and dephosphorylation in isolated nerve terminals (synaptosomes). In: Hemmings HC, Jr, editor. Regulatory protein modification: techniques and protocols. Totowa, New Jersey: Humana Press p 67-119.
27. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 267:1983-1989.
28. Sunahara RK, Dessauer CW, Gilman AG. 1996. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480.
29. Tanji J, Hoshi E. 2001. Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol 11:164-170.
30. 2+ and glutamate release. J Neurochem 53:1693-1699.
31. Turner TJ, Dunlap K. 1995. Pharmacological characterization of presynaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion. Neuropharmacology 34:1469-1478.
32. Vazquez E, Sanchez-Prieto J. 1997. Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur J Neurosci 9:2009-2018.
33. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. 2002. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99:13217-13221.
34. Wang SJ, Sihra TS. 2003. Opposing facilitatory and inhibitory modulation of glutamate release elicited by cAMP production in cerebrocortical nerve terminals (synaptosomes). Neuropharmacology 44:686-697.
35. 2+ channels in supporting hippocampal synaptic transmission. Science 264:107-111.
36. Wong ST, Athos J, Figueroa XA, Pineda W, Schaefer ML, Chavkin CC, Muglia LJ, Storm DR. 1999. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 23:787-798.
37. Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM. 2000. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 23:198-204.